Image

HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

This intervention study will use parent-, provider-, and health center-level strategies to promote HPV vaccination among 11-17 year olds receiving care in 8 community health centers in Florida, will explore factors related to the intervention effect, and will explore implementation outcomes of the intervention.

Description

The goals of this multi-level intervention study are to: 1) test whether HPV MISTICS intervention increases human papillomavirus (HPV) vaccine initiation and completion rates among 11-17-year-old adolescents in 8 Health Choice Network-affiliated community health centers in Florida. 2) Explore other factors related to the intervention effect. 3) Explore implementation outcomes (i.e., reach, adoption, implementation, maintenance, and sustainability) and identify implementation barriers and facilitators with a focus on equity. The study will use parent-, provider-, and health center-level strategies to promote HPV vaccination.

Eligibility

Inclusion Criteria:

  • For Staff:
  • 18 years of age or older
  • Working within the participating Federally Qualified Health Center system
  • Able to read, write and speak English
  • For Providers:
  • 18 years of age or older
  • Working within the participating Federally Qualified Health Center system
  • Interacting with parents of adolescents ages 11-17
  • Able to read, write and speak English
  • For parents:
  • Parent of 11-17 year old child that has received care within the prior two months at one of the participating Federally Qualified Health Centers
  • Whose child has not initiated or completed the HPV vaccine series at the time of their last visit
  • Able to read, write and speak English or Spanish

Study details

Human Papilloma Virus (HPV) Vaccine

NCT05677360

H. Lee Moffitt Cancer Center and Research Institute

17 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.